The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Personalized characterization of diseases using sample-specific networks
Open accessAbstract
A complex disease generally results not from malfunction of individual molecules but from dysfunction of the relevant system or network, which dynamically changes with time and conditions. Thus, estimating a condition-specific network from a single sample is crucial to elucidating the molecular mechanisms of complex diseases at the system level. However, there is currently no effective way to construct such an individual-specific network by expression profiling of a single sample because of the requirement of multiple samples for computing correlations. We developed here with a statistical method, i.e. a sample-specific network (SSN) method, which allows us to construct individual-specific networks based on molecular expressions of a single sample. Using this method, we can characterize various human diseases at a network level. In particular, such SSNs can lead to the identification of individual-specific disease modules as well as driver genes, even without gene sequencing information. Extensive analysis by using the Cancer Genome Atlas data not only demonstrated the effectiveness of the method, but also found new individual-specific driver genes and network patterns for various types of cancer. Biological experiments on drug resistance further validated one important advantage of our method over the traditional methods, i.e. we can even identify such drug resistance genes that actually have no clear differential expression between samples with and without the resistance, due to the additional network information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Mathematical Statistics and Data Analysis
Rabinowitz, L. (1989) · Technometrics · doi:10.1080/00401706.1989.10488573 · Cited by 3,116
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467
Ideker, T., & Krogan, N. J. (2012) · Molecular Systems Biology · doi:10.1038/msb.2011.99 · Cited by 792
Network-based stratification of tumor mutations
Hofree, M., Shen, J. P., Carter, H., Gross, A., & Ideker, T. (2013) · Nature Methods · doi:10.1038/nmeth.2651 · Cited by 737
Gene expression profiling in breast cancer: classification, prognostication, and prediction
Reis-Filho, J. S., & Pusztai, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61539-0 · Cited by 729
Enrichment or depletion of a GO category within a class of genes: which test?
Rivals, I., Personnaz, L., Taing, L., & Potier, M.-C. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btl633 · Cited by 718
Hood, L., & Flores, M. (2012) · New Biotechnology · doi:10.1016/j.nbt.2012.03.004 · Cited by 648
Ji, H., Li, D., Chen, L., Shimamura, T., Kobayashi, S., McNamara, K., Mahmood, U., Mitchell, A., Sun, Y., Al-Hashem, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.022 · Cited by 462
Self-citationKufe, D. W. (2013) · Oncogene · doi:10.1038/onc.2012.158 · Cited by 437
p53 regulates a G 2 checkpoint through cyclin B1
Innocente, S. A., Abrahamson, J. L. A., Cogswell, J. P., & Lee, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2147 · Cited by 436
Pathway-based personalized analysis of cancer
Drier, Y., Sheffer, M., & Domany, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219651110 · Cited by 337
Liu, R., Wang, X., Aihara, K., & Chen, L. (2014) · Medicinal Research Reviews · doi:10.1002/med.21293 · Cited by 333
Self-citationHuman MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response
Wei, X., Xu, H., & Kufe, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.008 · Cited by 234
Part mutual information for quantifying direct associations in networks
Zhao, J., Zhou, Y., Zhang, X., & Chen, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522586113 · Cited by 230
Self-citationLuan, F. L., Ding, R., Sharma, V. K., James Chon, W., Lagman, M., & Suthanthiran, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00805.x · Cited by 206
Bhardwaj, N., & Lu, H. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti398 · Cited by 186
Estimating Sample-Specific Regulatory Networks
Kuijjer, M. L., Tung, M. G., Yuan, G., Quackenbush, J., & Glass, K. (2019) · iScience · doi:10.1016/j.isci.2019.03.021 · Cited by 182
Li, F., Han, X., Li, F., Wang, R., Wang, H., Gao, Y., Wang, X., Fang, Z., Zhang, W., Yao, S., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.001 · Cited by 169
Self-citationZhang, X., Zhao, J., Hao, J.-K., Zhao, X.-M., & Chen, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1315 · Cited by 169
Self-citationDNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
Clair, S. S., Giono, L., Varmeh-Ziaie, S., Resnick-Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 162
Zhang, X., Liu, K., Liu, Z.-P., Duval, B., Richer, J., Zhao, X.-M., Hao, J., & Chen, L. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts619 · Cited by 162
Self-citationModeling Biomolecular Networks in Cells
Chen, L., Wang, R., Li, C., & Aihara, K. (2010) · Springer eBooks · doi:10.1007/978-1-84996-214-8 · Cited by 151
Self-citationPersonalizing Oncology: Perspectives and Prospects
Mendelsohn, J. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3605 · Cited by 137
CCNB1 is a prognostic biomarker for ER+ breast cancer
Ding, K., Li, W., Zou, Z., Zou, X., & Wang, C. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.06.013 · Cited by 135
Identifying disease genes and module biomarkers by differential interactions
Liu, X., Liu, Z.-P., Zhao, X., & Chen, L. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000658 · Cited by 130
Self-citationBuilding a Personalized Medicine Infrastructure at a Major Cancer Center
Meric‐Bernstam, F., Farhangfar, C. J., Mendelsohn, J. M., & Mills, G. B. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3043 · Cited by 127
Gao, Y., Zhang, W., Han, X., Li, F., Wang, X., Wang, R., Fang, Z., Tong, X., Yao, S., Li, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms5629 · Cited by 124
Self-citationAubert, S., Fauquette, V., Hémon, B., Lepoivre, R., Briez, N., Bernard, D., SEUNINGEN, I. V., Leroy, X., & Perrais, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4905 · Cited by 121
Bodt, S. D., Proost, S., Vandepoele, K., Rouzé, P., & de Peer, Y. V. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-288 · Cited by 110
Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
Wang, X., Chen, J., Liu, J., You, C., Liu, Y., & Mao, Q. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3380-0 · Cited by 106
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor
Suzuki, T., Urano, T., Miki, Y., Moriya, T., Akahira, J., Ishida, T., Horie, K., Inoue, S., & Sasano, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00444.x · Cited by 104
Human Mucin 1 Oncoprotein Represses Transcription of the p53 Tumor Suppressor Gene
Wei, X., Xu, H., & Kufe, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3063 · Cited by 103
PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations
Li, Y., Guessous, F., Kwon, S., Kumar, M., Ibidapo, O., Fuller, L., Johnson, E., Lal, B., Hussaini, I., Bao, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1963 · Cited by 95
EdgeMarker: Identifying differentially correlated molecule pairs as edge-biomarkers
Zhang, W., Zeng, T., & Chen, L. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.05.041 · Cited by 92
Self-citationDiagnosing phenotypes of single-sample individuals by edge biomarkers
Zhang, W., Zeng, T., Liu, X., & Chen, L. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv025 · Cited by 91
Self-citationPersonalized identification of altered pathways in cancer using accumulated normal tissue data
Ahn, T., Lee, E., Huh, N., & Park, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu449 · Cited by 83
Yu, M., Zhan, Q., & Finn, O. J. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00026-3 · Cited by 74
Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells
Angeloni, S., Martin, M., García-Morales, P., Castro-Galache, M. D., Ferragut, J. A., & Saceda, M. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800497 · Cited by 73
Jiang, J. (2015) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2015.01.005 · Cited by 59
Cheung, C. W. Y., Vesey, D. A., Nicol, D. L., & Johnson, D. W. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00535.x · Cited by 57
A network-based gene-weighting approach for pathway analysis
Fang, Z., Tian, W., & Ji, H. (2011) · Cell Research · doi:10.1038/cr.2011.149 · Cited by 56
Self-citationWhole-exome sequencing reveals recurrent somatic mutation networks in cancer
Liu, X., Wang, J., & Chen, L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.002 · Cited by 34
Self-citationCan we deconstruct cancer, one patient at a time?
Blau, C. A., & Liakopoulou, E. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.09.004 · Cited by 34
p53 Binds to Estrogen Receptor 1 Promoter in Human Breast Cancer Cells
Rasti, M., Arabsolghar, R., Khatooni, Z., & Mostafavi‐Pour, Z. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9423-6 · Cited by 30
Kim, S. (2010) · Oncology Reports · doi:10.3892/or_00000856 · Cited by 21
Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines
Albert, H., Battaglia, E., Monteiro, C., & Bagrel, D. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.06.003 · Cited by 20
Wreschner, D. H., Zrihan‐Licht, S., Baruch, A., et al. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2443-4_3 · Cited by 18
Cited by
Network analysis methods for studying microbial communities: A mini review
Matchado, M. S., Lauber, M., Reitmeier, S., Kacprowski, T., Baumbach, J., Haller, D., & List, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.001 · Cited by 357
Nomura, S., Satoh, M., Fujita, T., Higo, T., Sumida, T., Ko, T., Yamaguchi, T., Tobita, T., Naito, A. T., Ito, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06639-7 · Cited by 269
Spearheading future omics analyses using dyngen, a multi-modal simulator of single cells
Cannoodt, R., Saelens, W., Deconinck, L., & Saeys, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-24152-2 · Cited by 124
Biomedical data, computational methods and tools for evaluating disease–disease associations
Xiang, J., Zhang, J., Zhao, Y., Wu, F.-X., & Li, M. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac006 · Cited by 49
Network control principles for identifying personalized driver genes in cancer
Guo, W.-F., Zhang, S.-W., Zeng, T., Akutsu, T., & Chen, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz089 · Cited by 44
Self-citation
Metadata
- Authors
- Liu, X., Wang, Y., Ji, H., Aihara, K., & Chen, L.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-09-04
- Volume
- 44
- Issue
- 22
- Pages
- e164-e164
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2508622936
- Cited by
- 317
- References
- 55
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.